-transparent.png){kind=logo}
In vitro converted, Epstein-Barr (EBV) genome-carrying cell lines showed a reduced ability to shed surface-bound antibodies, compared to their EBV-free parental B lymphoma lines. On the other hand, antibody degradation was higher with EBV-positive cells. Analysis of antibody-coated single cells revealed that cells which failed to redistribute or cap their ligand-bound surface components at 37 degrees C, were also capable of shedding bound antibody. This suggests that capping and shedding are essentially independent phenomena, although both may be influenced by the same virally induced change in the lateral mobility of membrane constituents.
Related Publications
E Yefenof, and
L Lundin, and
G Klein
November 1981,
Blut,
E Yefenof, and
L Lundin, and
G Klein
November 1976,
International journal of cancer,
E Yefenof, and
L Lundin, and
G Klein
March 1978,
Journal of virology,
E Yefenof, and
L Lundin, and
G Klein
July 1983,
International journal of cancer,
E Yefenof, and
L Lundin, and
G Klein
November 1977,
European journal of cancer,
E Yefenof, and
L Lundin, and
G Klein
November 1987,
International journal of cancer,
E Yefenof, and
L Lundin, and
G Klein
May 1974,
The Journal of experimental medicine,
E Yefenof, and
L Lundin, and
G Klein
November 1978,
Nature,
E Yefenof, and
L Lundin, and
G Klein
July 2006,
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
E Yefenof, and
L Lundin, and
G Klein
January 1977,
Proceedings of the National Academy of Sciences of the United States of America,
